Submit Paper

Article Processing Fee

Pay Online

           

Crossref logo

  DOI Prefix   10.20431


 

ARC Journal of Pharmaceutical Sciences
Volume 4, Issue 1, 2018, Page No: 17-19
doi:dx.doi.org/10.20431/2455-1538.0401004

NRF2 as a Developing Therapeutic Target

Nasrin Ghassemi barghi

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.

Citation : Nasrin Ghassemi barghi, NRF2 as a Developing Therapeutic Target ARC Journal of Pharmaceutical Sciences 2018, 4(1) : 17-19

Abstract

The transcription factor nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) belongs to the Cap 'N' Collar (CNC) family that contains a conserved basic leucine zipper (bZIP) structure. The key function of Nrf2 is to activate the cellular antioxidant response by inducing the transcription of anextensivecollection of genes that are able to prevent the damagi8ng effects of exogenous and endogenous insults, such as xenobiotic and oxidative stress. Nrf2 controls the cellular oxidant level and oxidant signaling by controlling the expression of three groups of ARE-dependent genes: drug metabolizing enzymes/transporters, antioxidant enzymes/proteins, and oxidant signaling proteins. Nrf2 participates in the regulation of oxidant-stimulated programmatic functions, including autophagy, inflammasome assembly, ER stress/UPR, mitochondrial biogenesis, and stem cell regulation.


Download Full paper: Click Here